These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 34798979)
1. Familial Predisposition and Genetic Risk Factors Associated with Pancreatic Cancer. Rustgi SD; Hilfrank KJ; Kastrinos F Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):1-12. PubMed ID: 34798979 [TBL] [Abstract][Full Text] [Related]
2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
4. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy. Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161 [TBL] [Abstract][Full Text] [Related]
5. Genetic Variants in Patients With a Family History of Pancreatic Cancer: Impact of Multigene Panel Testing. Zhu H; Welinsky S; Soper ER; Brown KL; Abul-Husn NS; Lucas AL Pancreas; 2021 Apr; 50(4):602-606. PubMed ID: 33939675 [TBL] [Abstract][Full Text] [Related]
6. Hereditary pancreatic cancer. Abe K; Kitago M; Kitagawa Y; Hirasawa A Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650 [TBL] [Abstract][Full Text] [Related]
8. The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice. Mohindroo C; De Jesus-Acosta A; Yurgelun MB; Maitra A; Mork M; McAllister F Surg Pathol Clin; 2022 Sep; 15(3):491-502. PubMed ID: 36049831 [TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes. Mizukami K; Iwasaki Y; Kawakami E; Hirata M; Kamatani Y; Matsuda K; Endo M; Sugano K; Yoshida T; Murakami Y; Nakagawa H; Spurdle AB; Momozawa Y EBioMedicine; 2020 Oct; 60():103033. PubMed ID: 32980694 [TBL] [Abstract][Full Text] [Related]
10. Germline genetic variability in pancreatic cancer risk and prognosis. Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625 [TBL] [Abstract][Full Text] [Related]
11. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening. Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556 [TBL] [Abstract][Full Text] [Related]
12. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Ohmoto A; Yachida S; Morizane C Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699894 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780 [TBL] [Abstract][Full Text] [Related]
14. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J; Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971 [TBL] [Abstract][Full Text] [Related]